ОбзорГрафикНовостиTraderScreen

ING Knock-Out VLK/  DE000NG9Q9V4  /

Frankfurt Zertifikate
20.12.2024  19:38:34 Изменение-0.040 Бид21:38:56 Предложение21:38:56 Базовый актив Цена исполнения Дата истечения Тип опциона
0.680EUR -5.56% 0.670
Величина цены спроса: 2,000		 0.790
Величина цены предложения: 2,000		 Van Lanschot Kempen ... 35.7856 EUR 31.12.2078 Call
GlobeNewswire 26.06 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire 25.06 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire 25.06 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire 30.05 Merus Announces Pricing of Upsized Public Offering of Common Shares
GlobeNewswire 28.05 Merus N.V. Announces Proposed Public Offering of Common Shares
GlobeNewswire 05.04 ORYZON to Provide Corporate Progress Updates at Several Events in April
GlobeNewswire 04.04 Oculis to Participate at Upcoming April Investor Conferences
GlobeNewswire 03.04 Pharming Group to participate in April investor conferences
GlobeNewswire 18.03 Transgene Announces Upcoming Investor Meetings
GlobeNewswire 04.03 Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 29.02 MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire 08.02 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 31.01 Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire 22.12.2023 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 10.10.2023 Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire 09.02.2021 SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire 09.02.2021 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 07.07.2020 Mid-Stabilisation Period Announcement
GlobeNewswire 26.06.2020 Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire 24.06.2020 Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire 19.06.2020 Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire 18.06.2020 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire 17.06.2020 Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire 03.06.2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire 22.01.2020 Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement